Chemotherapy

Chemotherapy, in its most general sense, is the treatment of disease by chemicals especially by killing micro-organisms or cancerous cells. In popular usage, it refers to antineoplastic drugs used to treat cancer or the combination of these drugs into a cytotoxic standardized treatment regimen.

What is Chemotherapy?

Chemotherapy literally refers to the treatment of certain diseases using specific chemicals that are destructive to malignant cells or to the causative agent of a disease such as a bacteria or virus. Therefore, the treatment can be broadly divided into two categories - cancer chemotherapy and antimicrobial chemotherapy.

Chemotherapy Types

How Chemotherapy Affects Daily Living

History of Chemotherapy

What is 'Chemo Brain'?

Chemotherapy Principles

Does Scalp Cooling Prevent Hair Loss During Chemotherapy?

Chemotherapy Treatment Schemes

Latest Chemotherapy News and Research

Eosinophils suppress tumor growth and recurrence in chordoma

Chordoma is a rare tumor characterized by poor prognosis, limited therapeutic options, and a high rate of recurrence. Despite advances in oncology, effective treatments for chordoma remain limited.

31 Jan 2026

Genetic ancestry influences tumor biology and survival in head and neck cancers

Genetic ancestry plays a key role in determining the behavior of head and neck tumors and may help explain why African-American patients survive for half as long as their counterparts of European ancestry, according to a new review study led by researchers from the University of Maryland School of Medicine's (UMSOM) Institute for Genome Sciences (IGS) and the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC).

31 Jan 2026

Researchers identify key factor to help improve treatment for glioblastoma

A groundbreaking study from Brown University Health researchers has identified a crucial factor that may help improve treatment for glioblastoma, one of the most aggressive and common forms of adult brain cancer.

30 Jan 2026

Palbociclib improves progression-free survival in HER2 positive breast cancer

PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the New England Journal of Medicine (NEJM).

30 Jan 2026

Characteristic features of bone marrow metastasis from non-hematolymphoid malignancies

Bone marrow metastasis (BMM) from non-hematolymphoid malignancies with resultant cytopenia(s) can mimic primary hematolymphoid disorders. This study aimed to investigate the clinical and pathological characteristics of BMM from non-hematopoietic tumors.

30 Jan 2026

ERC Proof of Concept grant supports promising CRISPR-based cancer treatment research

Microbiologist John van der Oost of Wageningen University & Research (WUR) has received an ERC Proof of Concept grant to further develop a promising CRISPR-based approach to cancer treatment. With funding of €150,000, he and researcher Christian Südfeld will spend the next eighteen months working on a method to kill cancer cells from within, while sparing healthy cells as much as possible.

30 Jan 2026

WHO launches guide to address mental health and stigma for people living with NTDs

Marking World Neglected Tropical Diseases (NTDs) Day, the World Health Organization (WHO) warns that millions of people living with NTDs continue to face profound and often unseen suffering due to discrimination, social stigma and untreated mental health conditions.

30 Jan 2026

Light-driven nanoparticles to target tumors

Researchers at NYU Abu Dhabi have developed a new light-based nanotechnology that could improve how certain cancers are detected and treated, offering a more precise and potentially less harmful alternative to chemotherapy, radiation, and surgery.

30 Jan 2026

Treating desmoplastic melanoma with immunotherapy before surgery can shrink or eliminate tumors

New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and aggressive skin cancer, with immunotherapy before surgery can dramatically shrink or even eliminate tumors, sparing patients from more aggressive surgeries and preserving their quality of life.

29 Jan 2026

Two-pronged therapeutic technology for cancer wins Pfizer Prize for Biomedical Research 2026

Whereas conventional treatments such as chemotherapy and radiotherapy show their limitations in battling certain advanced cancers, immunotherapy and therapeutic vaccines have opened up a new realm of hope for patients.

29 Jan 2026

New guide for clinicians aims to improve UTI care

Millions of times a year, Americans seek urgent treatment for painful, embarrassing urinary tract infections.

29 Jan 2026

Combination therapy improves cognition in Alzheimer’s models

In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed medical benefits including anti-inflammatory and neuroprotective properties.

28 Jan 2026

Clinical trial aims to improve survival for patients with recurrent head and neck cancer

A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients whose disease returns after radiation therapy – a setback that affects up to 40% of patients and is often associated with poor outcomes.

27 Jan 2026

Orphan noncoding RNAs define cancer identity and enable blood-based monitoring

We knew we had something interesting with T3p, a single small RNA found in breast cancer but absent from normal tissue.

24 Jan 2026

Dual-responsive nanodelivery system enhances immunotherapy efficacy in metastatic bladder cancer

Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and the 5-year survival for advanced/metastatic disease is <10%.

24 Jan 2026

FDA warns consumers about fake cancer cures sold online

Beware of products claiming to cure cancer on websites or social media platforms, such as Facebook and Instagram. According to Nicole Kornspan, M.P.H., a consumer safety officer at the U.S. Food and Drug Administration (FDA), they're rampant these days.

22 Jan 2026

Pre-surgical medication use grows for pancreatic, gynecologic, and abdominal lining cancers

The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a substantial rise in medication treatments, such as chemotherapy, immunotherapy, and hormone therapy, used before surgery to treat many cancers, often allowing less invasive surgery and helping clinicians assess how a patient's cancer responds to medication to guide the most effective treatment options.

22 Jan 2026

Moffitt researchers develop a new way to predict how cancer cells evolve

Researchers at Moffitt Cancer Center have developed a new way to predict how cancer cells evolve by gaining and losing whole chromosomes, changes that help tumors grow, adapt and resist treatment.

22 Jan 2026

FIU's personalized cancer treatment shows promise

Researchers at FIU are advancing a personalized approach to cancer treatment that is showing increasingly promising results for patients with hard-to-treat disease, supported by new philanthropic investment that is helping expand the science behind the work.

22 Jan 2026

Chemotherapy-induced gut changes trigger anti-metastatic immune response

Chemotherapy commonly damages the intestinal lining, a well-known side effect. But this injury does not remain confined to the gut.

22 Jan 2026

Chemotherapy

Overview

Chemotherapy Types

How Chemotherapy Affects Daily Living

History of Chemotherapy

Feature Articles

What is 'Chemo Brain'?

Chemotherapy Principles

Does Scalp Cooling Prevent Hair Loss During Chemotherapy?

Chemotherapy Treatment Schemes

Latest Chemotherapy News and Research

Eosinophils suppress tumor growth and recurrence in chordoma

Genetic ancestry influences tumor biology and survival in head and neck cancers

Researchers identify key factor to help improve treatment for glioblastoma

Palbociclib improves progression-free survival in HER2 positive breast cancer

Characteristic features of bone marrow metastasis from non-hematolymphoid malignancies

ERC Proof of Concept grant supports promising CRISPR-based cancer treatment research

WHO launches guide to address mental health and stigma for people living with NTDs

Light-driven nanoparticles to target tumors

Treating desmoplastic melanoma with immunotherapy before surgery can shrink or eliminate tumors

Two-pronged therapeutic technology for cancer wins Pfizer Prize for Biomedical Research 2026

New guide for clinicians aims to improve UTI care

Combination therapy improves cognition in Alzheimer’s models

Clinical trial aims to improve survival for patients with recurrent head and neck cancer

Orphan noncoding RNAs define cancer identity and enable blood-based monitoring

Dual-responsive nanodelivery system enhances immunotherapy efficacy in metastatic bladder cancer

FDA warns consumers about fake cancer cures sold online

Pre-surgical medication use grows for pancreatic, gynecologic, and abdominal lining cancers

Moffitt researchers develop a new way to predict how cancer cells evolve

FIU's personalized cancer treatment shows promise

Chemotherapy-induced gut changes trigger anti-metastatic immune response

Cancer Research - Second Edition eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Chemotherapy

Overview

Feature Articles

What is 'Chemo Brain'?

Chemotherapy Principles

Does Scalp Cooling Prevent Hair Loss During Chemotherapy?

Chemotherapy Treatment Schemes

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in